International Conference on
Heart & Clinical Cardiology Research

 Theme  :  Novel Perspectives on Clinical Cardiology and Heart Diseases

  November 14-15, 2019


 Conference Brochure  Abstract Submission  Organizing Committee  Conference Program

Heart Congress 2019

Coalesce Research Group feels great to invite you all to attend the International Conference on Heart & Clinical Cardiology Research at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and vascular devices have been developed which helped for the treatment of cardiac disorders, replacement and repair therapy.

Coalesce Research Group is an USA based emerging open access publisher and International Conference Event organizer which owe to serve the scientific community by serving the high quality genuine research work from eminent scientists, professors, scientific research communities in all fields of medicine, clinical, life science, engineering and technology to the Research Scholars, Students, Libraries, Educational Institutions, Research centers and industries with the aim of "Enhance your Research" in the respective fields.

Dear Friends and Colleagues,

On behalf of the Organizing Committee, I would like to invite you all to "International Conference on Heart & Clinical Cardiology Researches" in Osaka, Japan
It will be held in the Hotel Agora Regency Sakai, Osaka. We wish to make the congress a huge success with cooperation from all of you. It would be a historic meeting which will serve as a springboard to strongly advance the world-wide advancement of cardiac health in both scientific and clinical aspects, thus "Accelerating the Pace of Change".
You can participate in very active discussions and cutting-edge lectures by the world's top scientists and cardiologists in all fields of cardiology including clinical carrdiology, research and future plans in Cardiology.
Osaka is accessible to all countries and has direct flights for most Asian, European, African countries as well as to USA and Australia. We are confident that you will not have issues with travel and stay. The local organising committee is at your service in case you need any assistance.
The Organizing Committee of Heart Congress 2019 looks forward to welcoming you in Osaka, Japan for Heart Congress 2019.

Best Wishes,
Enrique Otero Chulian

Cardiologist, Vithas Affilliation Hospital, Spain

Track 1: Heart Disease & Failure

Heart disease implies the conditions that affect your heart. The heart disease umbrella includes blood vessel diseases such as heart rhythm problems (arrhythmias), coronary artery disease, and inborn heart defects i.e. Rheumatic heart disease, congenital heart defects, Ischemic heart disease, Hypertensive heart disease, hypertension and many more. Heart failure is a situation in which your heart can't pump enough blood to meet your body's needs. The term “heart failure” doesn't imply that your heart has stopped or is about to stop working. Heart failure is a serious condition that requires intensive medical care. People with heart failure tire easily and have to limit your activities. Congenital Heart Diseases can lead to heart failure by weakening the heart muscle over time.

  • Angiology
  • Atrial fibrillation
  • Cardiomyopathy
  • Cerebrovascular disease
  • Ischemia heart disease
  • Congenital heart disease and regeneration
  • Coronary artery diseases
  • Congestive heart failure
  • Myocarditis-Left side heart failure
  • Heart attack

Track 2: Cardiac and Cardiovascular Research

Cardiac research supports awareness of the treatment of risk factors for heart disease. and the most comprehensive provider of cardiovascular services for the prevention, detection, treatment and treatment of cardiovascular diseases. Effective scientific research and scientific work in the field of cardiology, angiology, hypertension and cardiac and vascular surgery reduces clinical events and premature death in people at risk of cardiovascular disease. Cardiovascular disease is treatable and curable in initial stages of treatment primarily focused on nutrition and lifestyle habits. Cardiac research focuses on the treatment of diseases and new theories of diagnosis of blood vessels and vascular system or heart.

Track 3: Heart Devices

These devices are electronic gadgets that assistance circle a heart that is utilized too in part or totally to supplant the capacity of a coming up short heart. The improvement of these remote heart screens denotes another time in drug and the progress from social insurance to populace levels to customized medication where proper patients are outfitted with cutting edge biosensors which thus have their information prepared by complex expectation calculations will occur. Pacemakers, defibrillators, biosensors are cardiovascular gadgets used to treat coronary illness.

  • Cardiac resynchronization therapy
  • Cardiac pacemaker
  • Defibrillation technology
  • LV reverse remodeling
  • Intra-aortic balloon pump (IABP)

Track 4: Heart Diagnosis & Medication

The medical diagnosis is based on information from sources such as physical examination findings, interviews with the patient and his/her family, a patient's and family history and clinical findings in laboratory and radiological studies. Diagnosis of heart disease can be performed by various methods, such as imaging techniques, angiography, surgery, electrophysiology, radiography, etc. Medical care is is of utmost importance after diagnosis of heart disease. The goal of treatment is to stabilize the condition, to control symptoms in the long term, and to provide the drug if possible. Change in lifestyle & eating habits, reducing stress are key to managing heart disease, but the basics of conventional care are drugs and surgery

Track 5: Cardiac Nursing

Cardiac nursing is a nursing forte that deals with the patients who are experiencing different conditions of the cardiovascular framework. Cardiovascular medical caretakers help to treat conditions, for example, unsteady angina, congestive heart disappointment, coronary corridor infection, cardiomyopathy, myocardial localized necrosis and cardiovascular dysrhythmia under the direction of a cardiologist. Cardiovascular medical attendants perform postoperative consideration on a careful unit, heart observing, push test assessments, vascular checking, and wellbeing appraisals. Heart attendants work in a wide range of situations, including coronary consideration units (CCU), heart catheterization, working theaters, escalated care units (ICU), heart recovery focuses, heart medical procedure wards, clinical research, cardiovascular concentrated consideration units (CVICU), and heart medicinal wards.

  • Cardiac assessment nursing
  • Cardiac surgery nursing
  • Electrophysiology
  • Stress test evaluations
  • Pediatric cardiac nursing
  • Telemetry care

Track 6: Diabetes, Obesity & Stroke

Obesity influences to heart failure by endorsing hypertension, diabetes, and CHD

  • Dyslipidemia and risk of Stroke
  • Diabetic,Metabolic Syndrome and Stroke prevention
  • Metabolic Syndrome and Ischemic Stroke
  • Weight and diabetes

Track 7: Cardiovascular Regeneration

Cardiovascular Regeneration is a effort to fix irreversibly harmed heart tissue through front line science, including stem cell and stem cell treatment. Reparative devices have been intended to reestablish harmed heart tissue and capacity by the characteristic capacity of the body to recover. Together, patients and suppliers find regenerative arrangements that reestablish, recharge and reuse patients' very own reparative abilities.

  • Biomimetic heart valve replacement
  • Cardio myocyte proliferation
  • Cardiac remodelling
  • Cardiac regenerative therapy
  • Heart repair, heart tissue regeneration and stem cells
  • Stem cells for myocardial regeneration
  • Tissue graft cardiac cell replacement
  • Trans-differentiation during heart regeneration

Track 8: Cardiac Electrophysiology

Cardiac electrophysiology is the study of elucidating, diagnosing, and treating the electrical activities of the heart. It is usually used to describe studies of such phenomena by invasive (intracardiac) catheter recording of spontaneous activity as well as of cardiac responses to programmed electrical stimulation (PES). It typically measures the response of the injured or cardiomyopathic myocardium to PES on specific pharmacological regimens in order to assess the likelihood that the regimen will successfully prevent potentially fatal Sustained Ventricular Tachycardia (VT) or Ventricular Fibrillation VF (VF) in the future. Sometimes a series of EPS drug trials must be conducted to enable the cardiologist to select the one regimen for long-term treatment that best prevents or slows the development of VT or VF following PES. Such studies may also be conducted in the presence of a newly implanted or newly replaced cardiac pacemaker or AICD.

Track 9: Pediatric Cardiology

Pediatric Cardiology is a new specialty practice concentrated on providing wide-ranging care and management of cardiac conditions in children. Cardiologists can discuss on their most happening research related to children. Pediatric cardiology is a part of prescription managing different heart related issues in children, babies, new born. The field consolidates remedial end and treatment of natural heart infections; coronary hall infirmity, heart disillusionment, valvular coronary ailment and electrophysiology in children and the Physicians who have some aptitude in this field of arrangement are called Pediatric cardiologists. This generally occurred in the youths as a result of Plaque create thickens and cements course dividers, which can stifle blood travel through your supply courses to your organs and tissues. Atherosclerosis is furthermore the most outstanding explanation behind Pediatric cardiovascular ailment. There are a wide scope of sorts of heart issues that can impact kids. They fuse inherent heart surrenders, viral defilements that impact the heart, and even coronary ailment increased later in youth due to maladies or genetic issue.

  • Double Outlet Right Ventricle
  • Pulmonary Atresia
  • Tetralogy of Fallot
  • Transposition of Great Arteries

Track 10: Cardiology - Future Medicine

  • Cardiovascular magnetic resonance imaging
  • Cardiac MRI
  • Computed tomography
  • Clinical uses of cardiac imaging
  • Noninvasive cardiac imaging
  • Physician impairment

Track 11: Case Reports on Cardiology

This track is aimed to discuss original clinical research/studies and case reports related to Cardiology in the field of Medicine and Surgery. Case reports related to arrhythmia, congenital heart disease, congestive heart failure, valvular heart disease, vascular disease and cardiomyopathy.

  • Arrhythmias
  • Atherosclerosis
  • Cardiac Surgery
  • Clinical studies
  • Heart Regeneration
  • Heart Failure
  • Heart Diagnosis
  • Myocardial and Pericardial Disease
  • Vascular Heart Disease

Track 12: Clinical Cardiology

Clinical Cardiology is a branch of medicine deals with disorders of the heart as well as parts of the circulatory system. The Section of Clinical Cardiology access to specialized inpatient and outpatient heart care and treatment of heart problems such as angina, artery problems, valvular heart disease, and heart failure. The one who specialize in this field of medicine are called cardiologists, primary mission is to deliver high quality, cardiovascular care to all of our patients. Pediatric cardiologist is pediatricians who have received extensive training in diagnosing and treating children's cardiac problems

  • Cardiovascular Medicine
  • Modern practices in cardiovascular therapy
  • Cardiac progenitor cells
  • Percutaneous Coronary Intervention (Pci)
  • Hypertension for the primary care clinician
  • Preventive Medicine

Track 13: Heart Diagnosis & Heart Diseases

Persons with implanted heart devices resume their normal daily activities after full recovery from cardiac surgery. However, there may be certain situations that your doctor will ask you to avoid. Physicians and Medical practitioners will provide guidance for your particular condition, but these are some general guidelines to follow after complete recovery. With any medical procedure, there are risks involved in a heart device implant and the results may vary. Talk to your doctor about any specific concerns or activities — such as returning to work or participating in exercise or sports — that you may have. After receiving your heart device you may also have to be under medication as directed by your physician and periodically your doctor will need to monitor your device.

  • Cardiac Resynchronization Therapy (CRT)
  • Left ventricular Assist Device (LVAD)
  • The Heart Ware’s Ventricular Assist System
  • The Levacor Heart Pump

Track 14: Hypertension

Hypertension, also known as high blood pressure is a long term medical condition in which the blood pressure in the arteries is frequently elevated. High blood pressure usually does not cause symptoms. Long term high blood pressure is a main risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease. It is classified into primary high blood pressure or secondary high blood pressure. Due to nonspecific lifestyle and genetic factors about 90–95% of cases are primary hypertension. Human lifestyle factors that increase the risk of hypertension constitute excess salt, excess body weight, smoking, and alcohol. The rest 5–10% cases are due to secondary hypertension, which constitutes chronic kidney disease, narrowing of the kidney arteries, a hormone-related disorder, or the use of birth control pills. Blood pressure is calculated by two measurements, the systolic and diastolic blood pressures, these are the maximum and minimum pressures, respectively. At rest, normal blood pressure is within the range of 100–140 mm of mercury (mmHg) during systole and 60–90 mmHg diastoles.

  • Malignant Hypertension
  • Essential Hypertension
  • Secondary Hypertension
  • Isolated Systolic Hypertension

Track 15: Interventional Cardiology

Interventional cardiology –is the branch of cardiology that handles with the specific Cather based techniques to various structural heart diseases, non-surgical procedures for treating cardiovascular diseases. In addition, for an acute myocardial infarction the procedure involved in interventional cardiology for acts as a best standard of care. It involves in elimination of clots from coronary arteries and implementation of stents and balloons through a small hole made in a major artery. Coronary intervention will remain the dominant procedure for the Interventional cardiologist, which leads to the development of new procedures in coming decade in proportional to the population growth. It is expected that interventional cardiology craves a new attention in the growth of valvular heart disease intervention.

  • Cardiovascular surgery procedures
  • Cardiac catheterization.
  • Coronary and valvular intervention
  • Interventional cardiac devices

Track 16: Cardiac Oncology

Cardiac Oncology is a new field in cardiology. Cardio-Oncology is the heart conditions in patients who have been treated for malignant growth. Cardiologists can survey the potential danger of creating heart conditions among patients while they are taking the specific kinds of malignant growth medications, or following radiation treatment to the chest.

  • Chemotherapy-related cardiac dysfunctions
  • HER2-directed therapy
  • Intra-cardiac tumor
  • Malignancy of the heart Targeting Tyrosine Kinases for Cancer Therapy
  • Novel Targeted Therapies
  • Platinum-Based Chemotherapy Agents
  • Radiation-Induced Heart Disease
  • Vascular toxicities

Track 17: Molecular Cardiology

Molecular cardiology is a new branch of cardiovascular study for the treatment of cardiac diseases by using the molecular and biological techniques. Transgenic techniques include the gene therapy and stem cell therapy for cardiovascular diseases and cardiac research. It has changed our intellectual thinking of cardiovascular development, disease etimology and electro-pathophysiology. It has also given an avenue for understanding and controlling cardiovascular diseases.

  • Gene Analysis in the Diseased Heart
  • Transgenic Techniques in Cardiac Research
  • Gene Transfer & Gene Therapy for Cardiovascular Disease
  • Medical Genetics
  • Parabiosis and gene therapy
  • Cardiac hypertrophy
  • Transgenic techniques in cardiac research
  • Integrins and chemokine receptors in heart physiology

Track 18: Cardiac Surgery

Cardiovascular surgery which is also known as cardiothoracic surgery is operated on the heart vessels by cardiac surgeons and it is the field of medicine involved in surgical treatment of organs inside the thorax. There are five types of cardiac surgery 1) Open heart surgery 2) Modern beating-heart surgery 3) Heart transplant 4) Coronary artery bypass grafting 5) Minimally invasive surgery and surgeries are done to treat complexity of ischemic heart disease, correct congenital heart disease, or treat valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis and advancement of cardiac surgery and cardiopulmonary bypass techniques has greatly reduced the mortality rates of humans with cardiothoracic disabilities. The surgery requires postoperative care to avoid complications. Laceration care is needed to avoid infection and minimize scarring. Swelling and loss of appetite are common, As mentioned Coronary artery bypass grafting (CABG) is the most common type of heart surgery. CABG improves blood flow to the heart

  • Open heart surgery
  • Cardiomyopathies
  • Adult congenital heart disease and sports cardiology
  • Cardiac transplantation
  • Surgery for lV dysfunction
  • Mechanical support left ventricular assist devices
  • Therapeutic and physiologic issues surrounding heart valve surgery
  • Angioplasty or surgery for multivessel coronary artery disease
  • Advances in congenital heart disease
  • Transmyocardial revascularization (TMR)
  • Minimally invasive heart surgery
  • Cardiomyoplasty
  • Heart transplant
  • Bypass surgery
  • Artificial heart valve surgery
  • Cardiothoracic surgery

Track 19: Cardiovascular Biology

Cardiovascular biology is the study that involves vascular function, structure, growth & development. This field includes different research, including studies of molecules, cells, organs and intact organisms. The main aim of vascular biology theory is to improve blood flow and perfusion of organs via the development of novel treatment approaches and tissue engineering of synthetic blood vessels and organs, identification of new therapeutic targets.

  • Angiogenesis
  • Cardiac regeneration
  • Heart development
  • Calcification
  • Cardiovascular diseases
  • Platelets
  • Cardiac hypertrophy
  • Cardiovascular genetics

Track 20: Cardiovascular Toxicology

Cardiovascular Toxicology is the field which essentially focuses to the antagonistic impacts on the heart or blood frameworks that outcome from presentation to lethal synthetic compounds. It expounds wellbeing information of unfavorable impacts of new cardiovascular meds. Pharmacology of vascular endothelium manages alterations of endothelial cells and the vasculature have a pivotal influence in the pathogenesis of a wide scope of the most appalling of human illnesses, as endothelial cells have the imperative job of taking an interest in the upkeep of patent and useful vessels.

  • Biomarkers
  • Development of novel anti-ischemic agents
  • Drug-induced cardiac toxicity
  • Novel anti-inflammatory therapies for atherosclerosis

Track 21: Cardiac Pharmacology

Cardiovascular pharmacology deals with the treatment of heart disease. Cardiac medications are used to treat the cardiac, circulatory and vascular system. Various cardiovascular agents are available to treat various cardiovascular conditions. Sodium, potassium, calcium channel blockers, ACE inhibitors and cardiac biomarkers. There are 6 associations and societies and the main association for cardiology medical agents in the US. 50 universities work on cardiac medications. Three new drugs were introduced in 2015. There are many types of cardiovascular drugs on the market that include cardiac glycosides, anticoagulants, antiarrhythmic agents, anti anginal agents and antihypertensive agents.

Track 22: Nano technology in Cardiac Science

Nanotechnology provides the tools to explore the frontiers of medical science at a cellular level. It also provides the novel techniques in treatment of a multitude of diseases, including cardiovascular disorders.

Track 23: Current Research in Cardiology

This Session will cover the most recent research related to cardiology and related research.

  • Development of Pacemakers and Cardiac Conduction System Lineages
  • Molecular Targets of Drug Therapies
  • Personalized Medicine in Cardiology
  • Role of platelets and antiplatelet therapy in cardiovascular disease
  • Real-world Evidence and Outcomes Research
  • Stem Cell Research on Cardiology

Speaker guidelines

For Speakers:
• Keep the number of slides in your Presentation to a minimum and follow the assigned slots.
• Please stop when signaled to do so by the Chair.
• Personal laptops should not be used unless in any unavoidable conditions.
• The Videos will not be recorded.
• Question Sessions, thanks and acknowledgement of the speakers will take place during the session or after completion of the session, so please stay until the end of the session.

For Poster
• Each poster should be approximately 1x1 M in Size The title, contents, text and the author’s information should be clearly visible even from 1-2 feet.
• Present numerical data in the form of graphs, rather than tables.
• If data must be presented in table-form, keep it Simple to be easily understandable.
• Visuals should be simple, clear and bold. Avoid acronyms and mathematical notations as much as possible.
• Posters with 800-1000 words or less are perfect.
• Avoid submitting compactly packed, highly worded- count posters.
• Categorize your poster into subdivisions, e.g., Introduction, Methods, Results; Discussion, Conclusions, and Literature Cited.
• Use bright colors to enhance the better visibility Besides your project, you can also include future research plans or questions.

Opportunities for Conference Attendees:

For Researchers & Faculty:
• Speaker Presentations
• Poster Display
• Symposium hosting
• Workshop organizing

For Universities, Associations & Societies:
• Association Partnering
• Collaboration proposals
• Academic Partnering
• Group Participation For Students & Research Scholars:
• Poster Presentation Competition (Winner will get Best Poster Award)
• Young Researcher Forum (Award to the best presenter)
• Student Attendee
• Group Registrations

For Business Speakers:
• Speaker Presentations
• Symposium hosting
• Book Launch event
• Networking opportunities
• Audience participation

For Companies:
• Exhibitor and Vendor Booths
• Sponsorships opportunities
• Product launch
• Workshop organizing
• Scientific Partnering
• Marketing and Networking with clients

Abstract Peer-review Process/Guidelines:
• The Reviewing Committee of Heart Conferences ensures high-quality peer review process for all abstracts submitted to the conference.
• The decision of abstract acceptance will be judged by a panel of experts emphasizing whether the findings and / or conclusions are novel and make useful contributions to the field.
• The committee operates a single / double-blind peer review process for all the abstracts submitted, where both the reviewer and the author remain anonymous.

The following are the steps that each abstract of Heart Conferences undergoes during the process of peer review:
• All submitted abstracts are reviewed by internal editorial team to ensure adherence to the conference scope and abstracts which have passed this initial screening are then assigned to the session chair / review committee for evaluation.
• Once the reviews have been received, the review committee decides to accept or reject a manuscript, or to request revisions from the author in response to the reviewers’ comments. If the decision tends to be minor revision or major revision, authors will be given 14 days to resubmit the revised abstract.

Criteria to be considered for Scoring:

The abstract should be reviewed according to the following criteria:
• Originality of concept/approach and level of innovativeness
• Significance/impact/relevance to conference theme
• Quality of research design/theoretical argument
• Conclusions and interpretations of results
• Presentation style: Coherence and clarity of structure

Why to attend?

Presenting Your Organization’s Work on a Global Stage:
As a speaker you will be presenting to a room full of senior representatives from all over the world, each providing a different perspective from the sector. Your organization’s expertise and knowledge will be showcased to key players in the field of Nursing, Health care and will be a unique platform to increase your reputation within the sector

New Places; New People:
Each time will be held at a different place, new and different people will attend. This can enlarge building collaborations and help you in developing new relationships.

Learn From Other Speakers:
As a speaker you will be provided with free access to three days of the conference and associated workshops and will be given the opportunity to hear from other senior representatives from the sector and consider problems and solutions in the field of nursing, our numerous Q&A sessions and panel discussions.

Discuss And Overcome Issues In The Field:
This conference offers unrivalled opportunities to work with other key leading experts from the Universities and Hospitals to discuss the main challenges in the sector and to come together to produce strategies to find solutions to these problems Competitive Advantage: You’ll stand out if you’re a sponsor and your major competitors aren’t. If your competitors have already decided to be sponsors, your sponsorship becomes even more important, to assert your comparative market strength and your commitment to healthy products.

Leading a Workshop:
By leading one of the renowned Workshops, you will be presented with a perfect forum for an in depth discussion and debate into a key issue. These sessions can vary in format from case-study-led debate with interactive breakout sessions to a presentation based discussion group on a topic that may need a particular in-depth focus.

The Opportunity to Collaborate and Sponsor:
While we determine our conference theme and flow, we invite our key sponsors to suggest potential speakers, Delegate and topics that might also enhance the program. That’s why it’s important to commit early to sponsorship, before the program is final.

To increase your presence at the event, why not chair the event, a day, or a specific session to present yourself and your organization as one the leading players in a specific topic area? As a chair, you will work closely with us and our line-up of senior level speakers to ensure an event’s success.


Organizing Committee

Abdelhamid Errachid

Abdelhamid Errachid

Cardiology Professor | France


Enrique Otero Chulian

Enrique Otero Chulian

Cardiologist | Spain


Markus Ferrari

Markus Ferrari

Director | Germany


Ian James Martins

Ian James Martins

Cardiologist | Australia


View More


Abdelhamid Errachid

Abdelhamid Errachid

Cardiology Professor | France


Enrique Otero

Enrique Otero

Cardiologist | Spain


Karim Brandt

Karim Brandt

Cardiology Senior Research Associate | Switzerland


Markus Ferrari

Markus Ferrari

Director | Germany


View More

Know Your Registration

$ 449

  • Access to all Conference Sessions
  • Opportunity to give a Keynote/ Plenary/ Poster Presentations/ Workshop
  • Opportunity to publish your Abstract in any of our esteemed Journals & in the Conference Proceedings Book Certificate Accredited by our Organizing Committee Member
  • Handbook & Conference Kit
  • Tea/Coffee & Snack
  • Lunch during the Conference

$ 399

  • Access to all Conference Sessions
  • Can meet the Experts of your Area of expertise arriving from 22+ different Countries
  • Participation Certificate Accredited by our Organizing Committee Member
  • Delegates are not allowed to present their papers in Oral or Poster sessions
  • Handbook & Conference Kit
  • Tea/Coffee & Snack
  • Lunch during the Conference

$ 349

  • Access to all Conference Sessions
  • Opportunity to give an Oral/ Poster Presentation
  • Opportunity to publish your Abstract in any of our esteemed Journals & in the Conference
  • Proceedings Book
  • Certificate Accredited by our Organizing Committee Member
  • Handbook & Conference Kit
  • Tea/Coffee & Snack
  • Lunch during the Conference